bicalutamide has been researched along with sphingosine kinase in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brizuela, L; Cuvillier, O; Dayon, A; Doumerc, N; Golzio, M; Malavaud, B; Martin, C; Mazerolles, C; Nogueira, L; Pirot, N; Rischmann, P; Serre, G; TeissiƩ, J | 1 |
1 other study(ies) available for bicalutamide and sphingosine kinase
Article | Year |
---|---|
Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival.
Topics: Androgens; Anilides; Animals; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Lipids; Male; Mice; Mice, SCID; Neoplasm Transplantation; Nitriles; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Tosyl Compounds | 2009 |